Evidence map›Paper›PMID 26038408›Full record

ArticleEmerging microbes & infections2012

Identification and characterization of a novel incompatibility group X3 plasmid carrying bla NDM-1 in Enterobacteriaceae isolates with epidemiological links to multiple geographical areas in China.

Pak-Leung Ho, Zhen Li, Wai-U Lo, Yuk-Yam Cheung, Chi-Ho Lin, Pak-Chung Sham, Vincent Chi Chung Cheng, Tak-Keung Ng, Tak-Lun Que, Kin-Hung Chow

Open access · goldAbstract read
In one paragraph

Article in Emerging microbes & infections, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. Molecular and genetic features of a blaAnnals of clinical microbiology and antimicrobials · 2025
    Article
  3. Article
  4. Article
  5. Molecular epidemiological analysis of blaAnnals of clinical microbiology and antimicrobials · 2024
    Article
  6. Article
  7. Comparative Genomics of an Emerging Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Characterization of a Novel Sequence Type (ST) 6758Infection and drug resistance · 2024
    Article
  10. Article
  11. Article
  12. First report of coexistence ofFrontiers in microbiology · 2023
    Article
  13. Molecular Characterization ofMicrobiology spectrum · 2022
    Article
  14. Review
  15. Tandem Repeat ofInfection and drug resistance · 2022
    Article
  16. Coexistence ofFrontiers in microbiology · 2022
    Article
  17. Genetic Characterization of an ST5571 HypervirulentInfection and drug resistance · 2022
    Article
  18. ISmSystems · 2021
    Article
  19. First Report ofMicroorganisms · 2021
    Article
  20. Frontiers in microbiology · 2021
    Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Pak-Leung HoDepartment of Microbiology, The University of Hong Kong , Hong Kong, China ; Carol Yu Center for Infection, The University of Hong Kong , Hong Kong, China.
Zhen LiDepartment of Microbiology, The University of Hong Kong , Hong Kong, China.
Wai-U LoDepartment of Microbiology, The University of Hong Kong , Hong Kong, China.
Yuk-Yam CheungDepartment of Microbiology, The University of Hong Kong , Hong Kong, China.
Chi-Ho LinCentre for Genomic Sciences, The University of Hong Kong , Hong Kong, China.
Pak-Chung ShamCentre for Genomic Sciences, The University of Hong Kong , Hong Kong, China.
Vincent Chi Chung ChengDepartment of Microbiology, Queen Mary Hospital, Hospital Authority , Hong Kong, China.
Tak-Keung NgDepartment of Clinical Pathology, Princess Margaret Hospital, Hospital Authority , Hong Kong, China.
Tak-Lun QueDepartment of Clinical Pathology, Tuen Mun Hospital, Hospital Authority , Hong Kong, China.
Kin-Hung ChowDepartment of Microbiology, The University of Hong Kong , Hong Kong, China.
University of Hong Kong · HKHospital Authority · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The New Delhi metallo-β-lactamase (NDM-1) is one of the most important resistance traits in Enterobacteriaceae. We characterized nine bla NDM-1 producing Enterobacteriaceae recovered from seven patients who have recently travelled or been treated in India (n=1) or mainland China (n=6) during December 2010-May 2012. All the China-linked patients had no links to the Indian subcontinent. The bla NDM-1 carrying plasmids belonged to the novel IncX3 (∼50 kb, in seven isolates including two Escherichia coli, two Klebsiella pneumoniae, one Citrobacter freundii, one Enterobacter aerogenes and one E. cloacae), IncA/C2 (∼140 kb, in one E. coli) or FII-F1B groups (∼110 kb, in one E. coli). Restriction fragment length polymorphism analysis of the seven IncX3 plasmids revealed identical pattern in six and two bands difference in the remaining one. The IncX3 plasmids carrying bla NDM-1 were epidemiologically linked to Guangzhou (n=1), Hunan (n=4), Haifeng (n=1) and Dongguan (n=1) in mainland China. Complete sequencing of the IncX3 plasmid pNDM-HN380 revealed that it was 54 035 bp long and encoded 52 open reading frames. The bla NDM-1 gene was found in a transposon-like structure flanked by ISAba125 and IS26, inserted into the plasmid genetic load region. The sequences of the bla NDM-1 containing module within the two IS elements were identical to those previously described for bla NDM-1-positive Tn125 in the plasmids or chromosome of Acinetobacter isolates. In summary, this is the first description of IncX3 plasmids carrying bla NDM-1. The findings indicate the worrisome involvement of an epidemic plasmid in the dissemination of NDM-1 in China.

Indexed as

antimicrobial resistancecarbapenemasesepidemiologyincompatibility groupsNDM-1plasmids

Identifiers

PMID26038408
PMCPMC3630922
OpenAlexW1987732109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.